Immix Biopharma IMMX
NASDAQ IMMX
$8.35 -0.16 (-1.88%)
At close: Oct 22, 2026 · 4:00 PM EDT

Immix Biopharma (IMMX) Net Debt Issuances and Repayments (2021)

Updated

Analysis

Immix Biopharma (IMMX) Net Debt Issuances and Repayments (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,144.40 Bn 1,112.99 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 634.88 Bn 554.74 Bn 17.30 Bn -4.36 Bn
3 AbbVie 500.40 Bn 473.51 Bn 12.70 Bn -2.00 Bn
4 Merck 356.05 Bn 310.43 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 301.50 Bn 265.49 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 264.72 Bn 238.40 Bn 12.86 Bn -2.46 Bn
7 Amgen 238.14 Bn 193.54 Bn 7.24 Bn -
8 Gilead Sciences 195.19 Bn 169.39 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.40 Bn 118.04 Bn 10.94 Bn 64.00 Mn
10 Immix Biopharma 515.27 Mn 283.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 100,000.00
Mar 31, 2021 100,000.00
API Access

Immix Biopharma Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=IMMX&period=max&api_key=YOUR_API_KEY